Importance of CA-125 in Patient Monitoring
The CA-125 test is a critical tool for monitoring ovarian cancer treatment efficacy and detecting recurrence. Its widespread adoption underscores its role in patient management. Improved test accuracy and integration with other diagnostics enhance its clinical value.
The CA-125 segment significantly contributes to Ovarian Cancer Diagnostics Market Growth, particularly in North America and Europe, with rising adoption expected in Asia-Pacific.
Read more: Ovarian Cancer Diagnostics Market Growth.
Advancements in next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies have enhanced the sensitivity and specificity of genetic tests for ovarian cancer. These innovations allow for the detection of a broader range of genetic mutations, facilitating earlier diagnosis and personalized treatment plans. The integration of these technologies into clinical practice is transforming the landscape of ovarian cancer diagnostics.